Concepedia

Dewi Harjanto

DH

14

Publications

1.5K

Citations

12

H-Index

2010

Active since

Affiliations

Rockefeller University(Current)

BioNTech (United States)

German Cancer Research Center

Boston University

Heidelberg University

Dewi Harjanto is an author at Rockefeller University specializing in medicine, matrix biology, and radiation oncology.

ORCID

Top concepts

Publications per year

2010–2023

14

Publications

14

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Patrick A. Ott, Siwen Hu‐Lieskovan, Bartosz Chmielowski et al. · Cell · 2020 · 699 citations · Full text

, , +6

Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction

Jennifer G. Abelin, Dewi Harjanto, Matthew Malloy et al. · Immunity · 2019 · 252 citations · Full text

, , +14

Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes

Asaf Poran, Dewi Harjanto, Matthew Malloy et al. · Genome Medicine · 2020 · 97 citations · Full text

The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection

Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg et al. · Cell · 2023 · 84 citations · Full text

Quantitative Analysis of the Effect of Cancer Invasiveness and Collagen Concentration on 3D Matrix Remodeling

Dewi Harjanto, Joseph S. Maffei, Muhammad H. Zaman · PLoS ONE · 2011 · 60 citations · Full text

, , +23

Rows per page

1–5 of 14